Evidence map›Paper›PMID 40575296›Full record

ArticleJACS Au2025

Near-Infrared-Activated Photocages Made to Order: Late-Stage Caging Protocol.

Marina Russo, Dominika Zielinska, Katarzyna Hanc, Andrea Ramundo, Delia Meier, Attila Szabo, Peter Štacko

Abstract read
In one paragraph

Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marina RussoDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Dominika ZielinskaDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Katarzyna HancDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Andrea RamundoDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Delia MeierDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Attila SzaboDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.ORCID https://orcid.org/0009-0006-8822-8027
Peter ŠtackoDepartment of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.ORCID https://orcid.org/0000-0002-9404-7269

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nature has perfected the reversible control over the activity of molecules and biomolecules in the human body. Photocages aim to mimic this control in space and time by using light as a trigger, and the field has witnessed many excellent contributions that extend their use to the tissue-penetrating region. Yet little attention has been paid to developing simple caging strategies that are crucial to translating photocages into a widely accepted tool outside the chemistry field. Here, we report a robust and user-friendly protocol that enables the installation of complex amine, thiol, and phenol payloads in a single step under mild conditions and using bench-stable intermediates. The protocol displays excellent compatibility with a range of payloads, manifested by caging hormones, neurotransmitters, a tripeptide, and many highly complex FDA-approved drugs, including antibiotics and anticancer agents. As a proof of concept, we applied this strategy to cage the clinically approved CDK4/6 inhibitor palbociclib and evaluated its near-infrared (NIR) light-dependent activation in modulating tumor-suppressing retinoblastoma protein. We anticipate that this user-friendly synthetic approach to accessing NIR-absorbing photocages will accelerate research across various scientific disciplines.

Indexed as

breast cancerCDK4/6cyaninelate-stagenear-infraredpalbociclibphotocageretinoblastoma protein

Identifiers

PMID40575296
PMCPMC12188420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.